Zenas BiopharmaZBIO
13F holders, Q4 2024 (December 31)65holders +21
30new positions
14sold out
3famous investors
$8.19avg. 13F price*
At the end of Q4 2024, 65 institutions reported holding Zenas Biopharma Inc. (ZBIO) in their 13F filings, up 21 from Q3 2024. 30 opened new positions and 14 sold out. The largest holders were SR One Capital Management, LP ($40.2M), Enavate Sciences Gp, LLC ($30.8M) and NEA Management Company, LLC ($21.4M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Zenas Biopharma Inc.
- CUSIP
- 98937L105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 30 | $16.8M |
| Exits | 14 | $8.4M |
All 13F filers, Q3 2024 → Q4 2024: 4,582,947 shares bought and 1,607,597 shares sold, net +2,975,350 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 65 holders
| SR One Capital Management, LP | 9.81% | No change | 4,911,539 | $40.2M |
| Enavate Sciences Gp, LLC | 22.12% | — | 3,761,359 | $30.8M |
| NEA Management Company, LLC | 1.21% | No change | 2,613,948 | $21.4M |
| Fairmount Funds Management LLC | 1.54% | No change | 1,892,806 | $15.5M |
| NVP Associates, LLC | 8.05% | No change | 1,838,482 | $15.1M |
| FMR LLC | 0.00% | Reduce -10.9% | 1,781,715 | $14.6M |
| Novo Holdings A/S | 0.79% | Add +39.1% | 1,600,000 | $13.1M |
| Deerfield Management Company, L.P. | 0.27% | No change | 1,562,942 | $12.8M |
| Vivo Capital, LLC | 1.09% | No change | 1,183,260 | $9.7M |
| Federated Hermes, Inc. | 0.02% | No change | 1,158,000 | $9.5M |
| Wellington Management Group LLP | 0.00% | Reduce -24.4% | 1,135,289 | $9.2M |
| BlackRock, Inc. | 0.00% | New | 1,006,558 | $8.2M |
| Vanguard Group Inc. | 0.00% | Add +552.9% | 979,323 | $8.0M |
| Rock Springs Capital Management LP | 0.27% | No change | 878,667 | $7.2M |
| Perceptive Advisors LLC | 0.17% | Reduce -35.0% | 744,035 | $6.1M |
| Pivotal bioVenture Partners Investment Advisor LLC | 4.07% | Add +13.2% | 736,645 | $6.0M |
| ArrowMark Colorado Holdings LLC | 0.07% | Add +109.2% | 627,669 | $5.1M |
| T. Rowe Price Associates Inc. | 0.00% | Add +5.0% | 511,220 | $4.2M |
| Morgan Stanley | 0.00% | Add +601.7% | 358,212 | $2.9M |
| Geode Capital Management, LLC | 0.00% | Add +1303.1% | 348,760 | $2.9M |
| State Street Corp. | 0.00% | New | 211,506 | $1.7M |
| Schroder Investment Management Group | 0.00% | New | 171,940 | $1.5M |
| Catalio Capital Management, LP | 0.34% | — | 187,184 | $1.5M |
| Eversept Partners, LP | 0.15% | Reduce -9.7% | 172,103 | $1.4M |
| Millennium Management | 0.00% | Add +14.9% | 134,896 | $1.1M |
| UBS Group AG | 0.00% | Add +223061.0% | 131,665 | $1.1M |
| Northern Trust Corp. | 0.00% | New | 124,246 | $1.0M |
| Charles Schwab Investment Management Inc. | 0.00% | New | 118,660 | $972K |
| Superstring Capital Management LP | 0.80% | No change | 111,605 | $914K |
| Citadel Advisors | 0.00% | Reduce -12.4% | 82,624 | $677K |
| Norges Bank | 0.00% | Reduce -11.7% | 66,202 | $542K |
| M&T Bank Corp | 0.00% | Add +151.7% | 62,622 | $512K |
| Gsa Capital Partners LLP | 0.03% | New | 56,039 | $459K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -68.2% | 42,174 | $345K |
| Rhumbline Advisers | 0.00% | New | 38,942 | $319K |
| Renaissance Technologies | 0.00% | New | 38,400 | $314K |
| Bank of New York Mellon Corp | 0.00% | New | 35,944 | $294K |
| Alps Advisors Inc. | 0.00% | New | 33,790 | $277K |
| JPMorgan Chase & Co. | 0.00% | New | 29,839 | $244K |
| Barclays PLC | 0.00% | Add +54.5% | 23,939 | $196K |
| Deutsche Bank AG | 0.00% | New | 22,990 | $188K |
| Bank of America Corp. | 0.00% | New | 21,575 | $177K |
| Nuveen Asset Management, LLC | 0.00% | New | 19,909 | $163K |
| BNP Paribas Financial Markets | 0.00% | New | 18,245 | $149K |
| Two Sigma Investments, LP | 0.00% | Add +31.1% | 17,045 | $140K |
| Birchview Capital, LP | 0.11% | New | 16,500 | $135K |
| Citigroup Inc. | 0.00% | New | 12,104 | $99K |
| Stoneridge Investment Partners LLC | 0.03% | New | 10,955 | $90K |
| MetLife Investment Management, LLC | 0.00% | New | 10,225 | $84K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 8,596 | $70K |
| Wells Fargo & Company | 0.00% | New | 7,982 | $65K |
| Corebridge Financial, Inc. | 0.00% | New | 7,640 | $63K |
| PNC Financial Services Group, Inc. | 0.00% | Add +66.7% | 6,417 | $53K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | — | 4,499 | $37K |
| STRS Ohio | 0.00% | New | 2,800 | $23K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,608 | $13K |
| Legal & General Group Plc | 0.00% | New | 1,519 | $12K |
| California State Teachers Retirement System | 0.00% | New | 1,144 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,117 | $9K |
| Royal Bank of Canada | 0.00% | New | 1,140 | $9K |
| Amalgamated Bank | 0.00% | New | 524 | $4K |
| Sterling Capital Management LLC | 0.00% | New | 226 | $2K |
| R Squared Ltd | 0.00% | — | 210 | $2K |
| MRP Capital Investments, LLC | 0.00% | No change | 35 | $287 |
| SBI Securities Co., Ltd. | 0.00% | — | 2 | $16 |
"% of holder's portfolio" is ZBIO's weight in each manager's 13F, not the share of Zenas Biopharma Inc. the manager owns.